List of Excipients in API avacopan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing avacopan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| ChemoCentryx Inc | TAVNEOS | avacopan | 73556-168 | FERRIC OXIDE RED | 2031-02-03 |
| ChemoCentryx Inc | TAVNEOS | avacopan | 73556-168 | FERRIC OXIDE YELLOW | 2031-02-03 |
| ChemoCentryx Inc | TAVNEOS | avacopan | 73556-168 | FERROSOFERRIC OXIDE | 2031-02-03 |
| ChemoCentryx Inc | TAVNEOS | avacopan | 73556-168 | GELATIN | 2031-02-03 |
| ChemoCentryx Inc | TAVNEOS | avacopan | 73556-168 | POLYETHYLENE GLYCOL 4000 | 2031-02-03 |
| ChemoCentryx Inc | TAVNEOS | avacopan | 73556-168 | POLYOXYL 40 HYDROGENATED CASTOR OIL | 2031-02-03 |
| ChemoCentryx Inc | TAVNEOS | avacopan | 73556-168 | POLYSORBATE 80 | 2031-02-03 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for avacopan
Excipient focus: FERRIC OXIDE RED
avacopan drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
avacopan drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
avacopan drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GELATIN
avacopan drug variants containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing GELATIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 4000
avacopan drug variants containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing POLYETHYLENE GLYCOL 4000
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 40 HYDROGENATED CASTOR OIL
avacopan drug variants containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing POLYOXYL 40 HYDROGENATED CASTOR OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYSORBATE 80
avacopan drug variants containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing POLYSORBATE 80
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
avacopan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| ChemoCentryx Inc | avacopan | 73556-168 |
| >Company | >Ingredient | >NDC |
avacopan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch